VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.

Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage ...

MARLBOROUGH, Mass., May 22, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX™ left ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

Pradaxa (dabigatran etexilate) capsules have received FDA approval for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib). The medication, ...

The association between frailty and clinical outcomes in older adults with NVAF hasn’t been thoroughly examined in real-world settings. New data finds frailty to be associated with cardiovascular and ...

Choice of direct oral anticoagulant (DOAC) mattered for clinical outcomes among adults with atrial fibrillation (Afib), a study based on U.S. insurance claims found. Apixaban (Eliquis) users had ...

Inside the human chest, a tireless engine performs a rhythmic masterpiece roughly one hundred thousand times a day. If you ...

Atrial fibrillation (AF) is the irregular and rapid beating of the atria. Patients with AF may be asymptomatic or may have symptoms such as fatigue, palpitations, chest pain, shortness of breath and ...